Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

15.8%

3 terminated out of 19 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (11)
Early P 1 (1)
P 2 (3)
P 3 (1)
P 4 (1)

Trial Status

Completed6
Unknown5
Terminated3
Recruiting2
Not Yet Recruiting2
Withdrawn1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07560462Not ApplicableNot Yet RecruitingPrimary

Budesonide Following Endoscopic Dilatation of Esophageal Strictures in Children.

NCT05561114Phase 3RecruitingPrimary

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

NCT06840561Phase 2CompletedPrimary

Local Triamcinolone Injection Combined With Fibrin Glue Spray in Preventing Esophageal Stricture After Big-range Endoscopic Submucosal Dissection for Esophageal Early Cancer

NCT05581173CompletedPrimary

Self-Assembling Matrix Forming Gel to Prevent Stricture Formation

NCT06643689Phase 2Not Yet RecruitingPrimary

Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms

NCT06626802Not ApplicableCompletedPrimary

Steroid Versus Mitomycin-C Use in Pediatric Benign Recurrent Esophageal Stricture

NCT06514079Not ApplicableRecruiting

Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children

NCT04406428Not ApplicableTerminatedPrimary

NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures

NCT03898661Early Phase 1Terminated

Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures

NCT04730076Not ApplicableWithdrawnPrimary

Balloon Dilation Methods for Benign Esophageal Stricture

NCT03885310Not ApplicableUnknownPrimary

INGEST I Pilot Study

NCT04221867Not ApplicableUnknownPrimary

Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)

NCT04524897Phase 4UnknownPrimary

The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children

NCT02069847Phase 2CompletedPrimary

Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy

NCT04372784Not ApplicableUnknownPrimary

Cryoablation for Benign Gastrointestinal Anastomotic Strictures

NCT04284826Not ApplicableCompletedPrimary

Mitomycin-C Injection Therapy in Refractory Esophageal Stricture

NCT02354716TerminatedPrimary

EndoFLIP Use in Upper GI Tract Stenosis

NCT03039608Not ApplicableCompletedPrimary

Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm

NCT00551824Not ApplicableUnknownPrimary

Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children

Showing all 19 trials

Research Network

Activity Timeline